Albert, that could always be a reason. However we are in need of a vaccine. Long term response will come later during clinical trials, not from recovered blood. I really think it has to do with, and has been speculated by others here a couple weeks ago, that we did not have the money to pay the final bill for the testing. And that’s alright. We don’t have money, however we should have gotten a quote on the costs to finish testing.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.